787640-25-9

Basic information

• Product Name: 4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride
• Synonyms: 4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride
• CAS NO: 787640-25-9
• Molecular Formula: C7H13ClN4
• Molecular Weight: 188.65792
• Mol File: 787640-25-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride(787640-25-9)
• EPA Substance Registry System: 4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride(787640-25-9)

Safety Data

• Hazardous Substances Data: 787640-25-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride serves as a crucial pharmaceutical intermediate, playing a significant role in the synthesis of various drugs due to its unique chemical structure and properties.
Used as an Antiviral Agent:
In the field of antiviral research, 4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride is used for its potential to inhibit viral RNA replication, making it a candidate for the development of treatments against viral infections.
Used in Cancer Treatment Research:
4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride is being investigated for its potential use in the treatment of cancer, as it may contribute to the development of novel therapeutic approaches for cancer patients.
Used in Neurological Disorder Treatment Research:
4-(1H-1,2,4-Triazol-1-yl)piperidinehydrochloride is also being studied for its possible applications in the treatment of neurological disorders, indicating its potential to address a broad range of health concerns.

Upstream product

• 141699-59-4 1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 158654-90-1 ter-butyl 4-(1H-1,2,4-triazol-1-yl) piperidine-1-carboxylate 

Relevant articles and documents

Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

The present invention is directed to compounds of the formula I: Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

HETEROCYCLIC CYCLOPENTYL TETRAHYDROISOQUINOLINE AND TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

HETEROARYLPIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of the formula (I): (wherein R>12345610 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

AMINO CYCLOBUTYLAMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of the formulas I and II : wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R15, R16, R17, R18, R19, R25, R26, Y, Z, l, m, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.